DAA19 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
Molecular |
brain |
Human |
ATP6V0D1 |
8.0% Decrease Gene Expression Level |
|
DAA20 |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
Molecular |
brain |
Human |
ATP6V1A |
7.0% Decrease Gene Expression Level |
|
DAA21 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
Molecular |
brain |
Human |
ATP6V1G2 |
7.0% Decrease Gene Expression Level |
|
DAA22 |
antizyme inhibitor 1 |
Molecular |
brain |
Human |
AZIN1 |
11.0% Decrease Gene Expression Level |
|
DAA23 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
Molecular |
brain |
Human |
B3GALNT1 |
22.0% Decrease Gene Expression Level |
|
DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
cerebellum |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
temporal lobe |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
frontal lobe |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA24 |
B-cell CLL/lymphoma 11A (zinc finger protein) |
Molecular |
brain |
Human |
BCL11A |
14.0% Decrease Gene Expression Level |
|
DAA25 |
bone morphogenetic protein 7 |
Molecular |
brain |
Human |
BMP7 |
20.0% Increase Gene Expression Level |
|
DAA27 |
chromosome 1 open reading frame 95 |
Molecular |
brain |
Human |
C1orf95 |
5.0% Decrease Gene Expression Level |
|
DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
frontal lobe |
Human |
C1QA |
98.4% Increase Gene Expression Level |
|
DAA2181 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
parietal lobe |
Human |
C1QA |
154.9% Increase Gene Expression Level |
|
DAA2169 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
hippocampus |
Human |
C1QA |
243.4% Increase Gene Expression Level |
|
DAA2182 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
parietal lobe |
Human |
C1QB |
288.1% Increase Gene Expression Level |
|
DAA2170 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
hippocampus |
Human |
C1QB |
391.4% Increase Gene Expression Level |
|
DAA2166 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
temporal lobe |
Human |
C1QB |
186.7% Increase Gene Expression Level |
|
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
frontal lobe |
Human |
C1QB |
166.8% Increase Gene Expression Level |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
frontal lobe |
Human |
C1QC |
126.1% Increase Gene Expression Level |
|
DAA2183 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
parietal lobe |
Human |
C1QC |
216.2% Increase Gene Expression Level |
|
DAA2167 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
temporal lobe |
Human |
C1QC |
154.3% Increase Gene Expression Level |
|
DAA2171 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
hippocampus |
Human |
C1QC |
323.4% Increase Gene Expression Level |
|
DAA2172 |
complement component 1, s subcomponent increases with age |
Molecular |
hippocampus |
Human |
C1S |
152.9% Increase Gene Expression Level |
|
DAA2184 |
complement component 1, s subcomponent increases with age |
Molecular |
parietal lobe |
Human |
C1S |
54.0% Increase Gene Expression Level |
|